A distribution glitch at one of Minnesota’s two medical marijuana providers has left some patients with little or no supply left for treatment of conditions such as chronic pain, epileptic seizures and Tourette syndrome.
One patient, Katie Kennedy, said she called LeafLine Labs on Monday because she had no cannabis left for the management of her chronic pain and only a two-day supply left for the management of her son’s Tourette syndrome and autism. She said a LeafLine representative told her it had none available until Friday, though it later provided a small quantity to get her son through the week.
“I will be in great pain by the end of the week,” said Kennedy, who suffers from fibromyalgia and chronic back problems.
In a written statement, LeafLine Chief Executive Dr. Andrew Bachman said the shortage is temporary and blamed it on the Thanksgiving holiday and delays at a third-party lab that must test its cannabis products before they can be distributed. LeafLine closed its Eagan facility for the week and directed clients to its St. Paul facility.
“LeafLine Labs has plenty of inventory, but due to some unforeseen delays at the lab, including the recent holiday, we are still waiting for our certificate of analysis to release more product to our patients,” he said.
Top image: © Americanspirit | Dreamstime.com
Source: Cannabis Business Times